BridgeBio Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.About BBIO
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.
BBIO Key Statistics
Stock Snapshot
As of today, BridgeBio Pharma(BBIO) shares are valued at $68.56. The company's market cap stands at 13.39B, with a P/E ratio of -19.09.
On 2026-10-23, BridgeBio Pharma(BBIO) stock traded between a low of $67.02 and a high of $68.86. Shares are currently priced at $68.56, which is +2.3% above the low and -0.4% below the high.
BridgeBio Pharma(BBIO) shares are trading with a volume of 2.4M, against a daily average of 2.45M.
During the past year, BridgeBio Pharma(BBIO) stock moved between $52.75 at its lowest and $93.42 at its peak.
During the past year, BridgeBio Pharma(BBIO) stock moved between $52.75 at its lowest and $93.42 at its peak.
BBIO News
BridgeBio Pharma reported peer reviewed and real world data updates on acoramidis in ATTR-CM, as well as Phase 3 readouts, a new trial initiation and regulatory...
BridgeBio Pharma (BBIO) just packed several late stage updates into a single stretch of October, including new real world data for Attruby, fresh encaleret resu...
Analyst ratings
92%
of 24 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.